Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Two Novel Compounds With Tri-Aryl Structures As Effectivanti-Breast Cancer Candidates In-Vivo Publisher



Afsharinasab A1, 2 ; Moayer F3 ; Amini M4 ; Choopani S2 ; Tahmasvand R2 ; Dehghani S2 ; Mousavi SZ1 ; Salimi M2
Authors

Source: Iranian Journal of Pharmaceutical Research Published:2020


Abstract

Prognosis of metastatic breast cancer is very poor which urges the necessity to develop novel potential drug candidates. We assessed two compounds with tri-aryl structures (A and B) for their potency to reduce primary breast tumor growth and lung metastasis in 4T1 mice model. MTT assay, 4T1 mammary mouse model, and immunohistochemistry experiments were used in this study. In-vitro results exhibited an anti–proliferative effect for compounds A and B towards MDA-MB-231 cancer cells. Our in-vivo results displayed that administered compounds A and B could suppress the size of the primary tumor and the number of lung metastatic foci in 4T1 BALB/c mice model. Histopathological analysis revealed that treatment of both compounds resulted in necrosis. Our findings provide new evidence that compound B may be promising for slowing the growth of tumor along with metastatic foci via COX-2 independent pathway. © 2020, Iranian Journal of Pharmaceutical Research. All rights reserved.
Related Docs
View other Related Docs
1. Two Novel Tri-Aryl Derivatives Attenuate the Invasion-Promoting Effects of Stromal Mesenchymal Stem Cells on Breast Cancer, Anti-Cancer Agents in Medicinal Chemistry (2019)
2. Apoptotic Effects of Two Cox-2 Inhibitors on Breast Adenocarcinoma Cells Through Cox-2 Independent Pathway, Journal of Cellular Biochemistry (2015)
3. A Novel Hydrazide Compound Exerts Anti-Metastatic Effect Against Breast Cancer, Biological research (2019)
Experts (# of related papers)
View all Related Experts
Mohsen Amini (3)
Alireza Foroumadi (3)
Other Related Docs
4. Novel Quinazolin-4(3H)-One Linked to 1,2,3-Triazoles: Synthesis and Anticancer Activity, Chemical Biology and Drug Design (2018)
5. Design, Synthesis and Biological Evaluation Of4-(Imidazolylmethyl)- 2-(4-Methylsulfonyl Phenyl)-Quinoline Derivatives As Selective Cox-2 Inhibitors and In-Vitro Anti-Breast Cancer Agents, Iranian Journal of Pharmaceutical Research (2016)
6. Anti-Neoplastic Effects of Aprotinin on Human Breast Cancer Cell Lines: In Vitro Study, Advances in Clinical and Experimental Medicine (2019)
7. Inhibitory Effect of Flavonoid Xanthomicrol on Triple-Negative Breast Tumor Via Regulation of Cancer-Associated Micrornas, Phytotherapy Research (2021)
8. Synthesis, Biological Evaluation, and in Silico Study of Novel Coumarin-Quinazoline Analogs As Potential Anti-Angiogenesis Agents, Results in Chemistry (2024)
9. Silibinin, Up-Regulates Chemokine Receptor Expression in Mda-Mb-231 Breast Cancer Cell Line, Bangladesh Journal of Medical Science (2015)
10. In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells Via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity, Molecules (2019)
11. Down-Regulation of Death Receptor-5 in Metastatic Cascade of Triple-Negative Breast Cancer, Turk Onkoloji Dergisi (2020)
12. Sodium Butyrate Promotes Apoptosis in Breast Cancer Cells Through Reactive Oxygen Species (Ros) Formation and Mitochondrial Impairment, Lipids in Health and Disease (2017)
13. An Experimental and Theoretical Approach of a Novel Phosphoramide Containing Naphthoquinone With Potential Cytotoxic and Apoptosis-Inducing Ability, Journal of Molecular Structure (2025)
14. Current Status and Future Prospects for Esophageal Cancer, Cancers (2023)
15. Efficacy and Safety of the Irinotecan, Capecitabine, and Oxaliplatin (Iox) Regimen in Metastatic Gastric Cancer: A Single Arm Phase Ii Trial, Middle East Journal of Cancer (2019)
16. Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?, Frontiers in Oncology (2021)
17. Evaluation of Inhibitory Effect and Docking Study of Triazolyl Chromanone Oxime Ether Derivatives on Aromatase Enzyme Effective in Breast Cancer, Journal of Mazandaran University of Medical Sciences (2023)
18. Xanthohumol Hinders Invasion and Cell Cycle Progression in Cancer Cells Through Targeting Mmp2, Mmp9, Fak and P53 Genes in Three-Dimensional Breast and Lung Cancer Cells Culture, Cancer Cell International (2023)
19. Design, Synthesis, Docking Studies, and Biological Activity of Novel Analogs of Cyclophosphamide As Potential Anticancer Agents, Current Medicinal Chemistry (2025)
20. Synthesis, Molecular Docking, and Biological Evaluation of Pyridin-3-Yl-Pyrimidin-2-Yl-Triazole Derivatives As Anti-Cancer Agents, Polycyclic Aromatic Compounds (2024)